Hong Kong Exchanges and Clearing (388) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Nov, 2025Executive summary
Achieved record revenue and profit for Q3 2025 and the first nine months of 2025, driven by robust volumes in Cash and Derivatives markets and strong IPO activity.
Maintained position as the world's top IPO venue YTD 2025, with a strong pipeline of 297 active applications as of 30 September 2025 and IPO/follow-on funds raised more than doubling year-over-year.
Advanced strategic initiatives including China market integration, market connectivity enhancements, new product launches, technology upgrades, and green finance partnerships.
Financial highlights
YTD Q3 2025 revenue and other income: HK$21.9b, up 37% YoY; Q3 2025: HK$7.8b, up 45% YoY and 8% QoQ.
YTD Q3 2025 profit attributable to shareholders: HK$13.4b, up 45% YoY; Q3 2025: HK$4.9b, up 56% YoY and 10% QoQ.
EBITDA for YTD Q3 2025: HK$17.2b, up 48% YoY; Q3 2025: HK$6.2b, up 59% YoY.
Basic EPS YTD Q3 2025: HK$10.62, up 45% YoY; Q3 2025: HK$3.88, up 56% YoY.
Headline ADT on the Stock Exchange: HK$256.4b, up 126% YoY.
Outlook and guidance
Strong IPO pipeline and continued global investor interest in Chinese assets expected to support future growth.
Ongoing focus on strategic initiatives to enhance liquidity, diversification, global connectivity, and product innovation.
Net Investment Income expected to be affected by margin collateral enhancements, fluctuating HIBOR, and External Portfolio redemption.
Latest events from Hong Kong Exchanges and Clearing
- Record revenue and profit in 2025, with robust growth and strategic expansion across all segments.388
Q4 202527 Feb 2026 - Record revenue and profit growth in 2024, driven by vibrant trading and IPO momentum.388
Q4 20247 Jan 2026 - Record Q1 2025 profit, revenue, and trading volumes driven by robust market activity.388
Q1 202525 Dec 2025 - Record revenue, profit, and IPO fundraising highlight robust growth and market leadership.388
Q2 20259 Dec 2025 - Record Q2 revenue and profit highlight robust derivatives and market innovation.388
Q2 20249 Dec 2025 - Record Q3 revenue and profit, strong segment growth, and major IPOs highlight market momentum.388
Q3 202413 Jun 2025